HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: IFRA's New Fragrance Standards; 'Green Beauty Barometer' Results; More

This article was originally published in The Rose Sheet

Executive Summary

The International Fragrance Association releases the 48th Amendment to its Code of Practice, which includes new standards derived via Quantitative Risk Assessment to minimize dermal-sensitization risks. In other news, market research firms highlight survey results underscoring the influence of "all-natural" marketing and celebrity endorsements on personal-care purchasing habits.

You may also be interested in...



Industry Groups Keeping Eye On Montana’s Fragrance-Disclosure Bill

The International Fragrance Association North America and Personal Care Products Council are monitoring state-level proposals in the US to require full fragrance ingredient disclosure, including a Montana bill that passed committee in February. IFRA NA head Farah Ahmed discusses the group’s related advocacy work.

BMS, Eisai Team Up To Accelerate Development Of Solid-Tumor ADC

The US firm gets development and co-commercial rights to MORAb-202 for $650m up front. BMS joins AstraZeneca, Merck & Co. and Gilead in recent ADC deal-making.

BIO 2021 Notebook: Best Practices For Business Development

The recently concluded BIO annual meeting included several sessions focused on the practice of business development. In this extra edition of our BIO 2021 notebook, Scrip collected observations about best practices for partnerships.

Related Companies

UsernamePublicRestriction

Register

RS019610

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel